Cafepharma Today

Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
BMS gets Q2 beat, raises full-year guidance as cost-cutting initiative continues
Big Pharma appears to be unfazed by IRA drug price negotiations
Indivior reaches $86 million opioid settlement with US states
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Boston Globe, MA
Friday, February 20, 2009 - 8:08am
Pharmaceutical Business Review
Friday, February 20, 2009 - 8:06am
Reuters, UK
Friday, February 20, 2009 - 7:17am
NY Times, NY
Friday, February 20, 2009 - 7:15am
Pharmaceutical Business Review
Friday, February 20, 2009 - 7:10am
Seeking Alpha
Friday, February 20, 2009 - 7:10am
tags:
Seeking Alpha
Friday, February 20, 2009 - 6:05am
Marketwatch
Friday, February 20, 2009 - 6:03am
Bloomberg
Friday, February 20, 2009 - 6:01am
Easy Bourse, France
Thursday, February 19, 2009 - 6:01pm
Mercury News, CA
Thursday, February 19, 2009 - 6:00pm
Yahoo/AP
Thursday, February 19, 2009 - 5:58pm
tags:
East Bourse, France
Thursday, February 19, 2009 - 3:47pm
Yahoo/AP
Thursday, February 19, 2009 - 3:43pm
tags:
Yahoo/Zacks.com
Thursday, February 19, 2009 - 3:37pm
Bizjournals.com
Thursday, February 19, 2009 - 10:10am

Pages

Latest Jobs

Freeman, Missouri, 64746
Agape Care Group
Wellington, Missouri, 64097
Agape Care Group
Napoleon, Missouri, 64074
Agape Care Group
Denton, Texas, Texas
Tris Pharma
Santa Monica, California
Lundbeck
San Diego, California, California
AbbVie
New Haven, Connecticut, Connecticut
AbbVie
New York City, New York
AbbVie
Los Angeles, California, California
AbbVie
Santa Monica, California
AbbVie

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.